| 1373116-06-3 | CAS No. 1373116-06-3, 1-(1-(1H-imidazole-1-carbonyl)piperidin-4-yl)-1H-imidazo[4,5-b]pyridin-2(3H)-one | 98% min (HPLC/GC) | | 3/25/2039 (Rimegepant) | | | | | ISO 9001;ISO 14001 | |
| 1373116-04-1 | CAS No. 1373116-04-1, (5S,6S,9R)-6-(2,3-difluorophenyl)-9-((triisopropylsilyl)oxy)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-5-aminedihydrochloride | 98% min (HPLC) | | 3/25/2039 (Rimegepant) | | | | 2022 | | |
| 1190363-46-2 | CAS No. 1190363-46-2, (6S,9R)-6-(2,3-Difluorophenyl)-6,7,8,9-tetrahydro-9-[[tris(1-methylethyl)silyl]oxy]-5H-cyclohepta[b]pyridin-5-one | 98% min (NMR) | | 3/25/2039 (Rimegepant) | | | | 2019 | ISO 9001 | |
| 913613-82-8 | CAS No. 913613-82-8, 2(1H)-Quinolinone,7-(4-chlorobutoxy) | 98% min | BREX-003 | 10/12/2032 (Brexpiprazole) | no stock for now | 5-10t | 1.5 Million USD | 2015 | GMP, ISO 9001, ISO 14001, ISO45001 | One of the main suppliers for Chinese market |
| 70500-72-0 | CAS No. 70500-72-0, 7-Hydroxyquinolinone | 98% min | BREX-001 | 10/12/2032 (Brexpiprazole) | 100kg | 30t | 17 Million USD | 2014 | GMP (Operation in GMP standard but without GMP certification), ISO 9001 | Export to India, Poland, Korea and Japan, one of the main supplier in China |
| 913614-18-3 | CAS No. 913614-18-3, 1-(1-Benzothiophen-4-yl)piperazine hydrochloride | 99% min | BREX-004 | 10/12/2032 (Brexpiprazole) | 50kg | 5-10t | 1.5 Million USD | 2015 | GMP, ISO 9001, ISO 14001, ISO 45001 | One of the main suppliers for Chinese market |
| 23995-88-2 | CAS No. 23995-88-2, 1-(1-METHYLPIPERIDIN-4-YL)PIPERAZINE | 98% min (GC) | | 10/7/2031 (Zavegepant) | | | | 2022 | ISO9001 | |
| 349535-15-5 | Cas No. 349535-15-5, 1-(1-METHYLPIPERIDIN-4-YL)PIPERAZINE 3HCL | 98% min (GC) | | 10/7/2031 (Zavegepant) | | | | 2022 | ISO9001 | |
| 855778-84-6 | Cas No. 855778-84-6, 3-(piperidin-4-yl)quinolin-2(1h)-one hydrochloride | 98% min (HPLC) | | 10/7/2031 (Zavegepant) | 2kg | | | 2023 | ISO 9001 | CDMO |
| 1414976-14-9 | Cas No. 1414976-14-9, methyl (2R)-2-amino-3-(7-methyl-1H-indazol-5-yl)propanoate dihydrochloride | 98.0% min (HPLC); 99.0% e.e (HPLC) | | 10/7/2031 (Zavegepant) | | | | | ISO 9001;ISO 14001;ISO 45001; GMP | |
| 1455358-06-1 | Cas No. 1455358-06-1, 1-(tert-butyl)-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one | | | 12/22/2041 (Ubrogepant) | | | | | | |
| 1375541-21-1 | CAS No. 1375541-21-1, (S)-2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxylicacid;(3'S)-1',2',5,7-Tetrahydro-2'-oxospiro[6H-cyclopenta[b]pyridine-6,3'-[3H] | 98% min (HPLC) | | 12/22/2041 (Ubrogepant) | | | | 2021 | ISO 9001 | |
| 1456803-37-4 | CAS No. 1456803-37-4, (3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)piperidine-3-aminium 4-nitrobenzoate | 98% min (HPLC) | | 12/22/2041 (Ubrogepant) | | | | 2021 | ISO 9001 | |
| 1456803-39-6 | CAS No. 1456803-39-6, (3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-3- aminium 4-methylbenzoate | 98% min (HPLC) | | 12/22/2041 (Ubrogepant) | | | | 2021 | ISO 9001 | |
| 1374248-77-7 | CAS No. 1374248-77-7, Ubrogepant | 98.0% min (HPLC/GC) | | 12/22/2041 (Ubrogepant) | | | | 2022 | ISO 9001 | |
| 188113-71-5 | Cas No. 188113-71-5, (R)-1-ACETYL-5(2-BENZENE SULPHONYL ETHENYL)-3-(N-METHYLPYRROLIDIN-2-YL-METHYL-1H-INDOLE | | | 11/1/2019 (Eletriptan) | | | | | | |
